Anti-beta Amyloid 1-42 antibody [EPR9296]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Anti-beta Amyloid 1-42 antibody [EPR9296] (ab180956) is a rabbit monoclonal antibody detecting beta Amyloid 1-42 in Western Blot, ELISA. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II
- ELISA
Supplier Data
ELISA - Anti-beta Amyloid 1-42 antibody [EPR9296] (AB180956)
Direct ELISA using ab180956.
Antigen concentration 1μg/ml.
Primary antibody used at 1/500 and 1/10000 dilution.
Goat anti-rabbit IgG (AP) secondary antibody used at 1/10000 dilution.
- WB
Supplier Data
Western blot - Anti-beta Amyloid 1-42 antibody [EPR9296] (AB180956)
All lanes:
Western blot - Anti-beta Amyloid 1-42 antibody [EPR9296] (ab180956) at 1/2000 dilution
Lane 1:
Abeta42 protein at 0.01 µg
Lane 2:
Abeta38 protein at 0.01 µg
Lane 3:
Abeta40 protein at 0.01 µg
Lane 4:
Abeta46 protein at 0.01 µg
Lane 5:
Abeta49 protein at 0.01 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 86 kDa
false
Related conjugates and formulations (2)
-
Anti-beta Amyloid 1-42 antibody [EPR9296] - BSA and Azide free (Detector)
-
Anti-beta Amyloid 1-42 antibody [EPR9296] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-beta Amyloid 1-42 antibody [EPR9296] (ab180956) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), ELISA in Human samples.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR9296] also available for your convenience: ab180956, Carrier free - ab240233, Carrier free - ab280993
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Amyloid beta 1-42 plays a central role in synaptic activity and neuronal health. While not inherently pathogenic its tendency to aggregate forms oligomers and fibrils which become toxic to neurons. This peptide contributes to synaptic dysfunction and neuronal cell death and is a major component of extracellular amyloid plaques found in brain tissue. Within the cellular environment amyloid beta 1-42 can interact with receptors membrane lipids and intracellular signaling mechanisms thereby affecting neuronal cell function.
Pathways
Amyloid beta 1-42 is important in the amyloidogenic pathway which is one of the critical components in APP processing. The pathway includes proteolytic enzymes like beta secretase (BACE1) and gamma secretase where misregulation may lead to excessive production or deposition of amyloid beta peptides. Another related pathway is the tau protein phosphorylation pathway which indirectly interacts with amyloid beta 1-42 due to shared signaling intermediates impacting tau stabilization and microtubule assembly in neurons.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in behavioral neuroscience 19:1619889 PubMed40727321
2025
Applications
Unspecified application
Species
Unspecified reactive species
Degenerative neurological and neuromuscular disease 14:143-155 PubMed39741909
2025
Applications
Unspecified application
Species
Unspecified reactive species
Addiction biology 29:e70006 PubMed39665499
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:3945 PubMed37402721
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neurology 13:1090900 PubMed36698894
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34884761
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biosensors 7: PubMed28726727
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com